Early Phase 1 B-cell Malignancy Clinical Trials

2 recruitingEarly Phase 1

What is a Early Phase 1 trial?

Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.

Showing 1–2 of 2 trials

Recruiting

Early Phase 1

Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors

B-cell LymphomaB-cell MalignancyB-Cell Leukemia

Wondercel Biotech (ShenZhen)30 enrolled1 locationNCT06662227

Recruiting

Early Phase 1

Anti-CD19-CAR-T Cells in Subjects With Relapsed/Refractory B Cell Malignancies

B-cell Malignancy

Shanghai First Song Biotechnology Co., LTD9 enrolled1 locationNCT06532630